Released Mar 24, 2014, after the close
10-Q filed Mar 24, 2014, 267 days after period end · 0001193125-14-112535
Q2 2013 · 10-Q
Revenue$97.64M$97.64M −12.5% vs Q2 2012−4.5% vs Q1 2013
Net Income-$3.01M-$3.01M N/M vs Q2 2012N/M vs Q1 2013
EPS Diluted-$0.16-$0.16 N/M vs Q2 2012N/M vs Q1 2013
Gross Profit$75,756,000−12.6%
Operating Income$6,920,000−58.4%
Operating Cash Flowderived$19,083,000+117.1%
Free Cash Flowderived$12,286,000+418.8%
Margins · derived
Gross margin77.6%−0.1 pt vs Q2 2012
Operating margin7.1%−7.8 pt vs Q2 2012
Net margin-3.1%−11.0 pt vs Q2 2012
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Revenue | $97.64M | $111.60M | $108.22M | $142.85M |
| Net Income | -$3.01M | $8.80M | $5.40M | $10.23M |
| EPS Diluted | -$0.16 | $0.46 | $0.29 | $0.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR